3-Fluorobenzyl chloride structure
|
Common Name | 3-Fluorobenzyl chloride | ||
---|---|---|---|---|
CAS Number | 456-42-8 | Molecular Weight | 144.574 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 173.3±15.0 °C at 760 mmHg | |
Molecular Formula | C7H6ClF | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 58.9±0.0 °C | |
Symbol |
GHS02, GHS05 |
Signal Word | Danger |
Name | 3-Fluorobenzyl chloride |
---|---|
Synonym | More Synonyms |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 173.3±15.0 °C at 760 mmHg |
Molecular Formula | C7H6ClF |
Molecular Weight | 144.574 |
Flash Point | 58.9±0.0 °C |
Exact Mass | 144.014206 |
LogP | 2.54 |
Vapour Pressure | 1.7±0.3 mmHg at 25°C |
Index of Refraction | 1.505 |
Water Solubility | 40 g/L (20 ºC) |
Symbol |
GHS02, GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H226-H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
Hazard Codes | C:Corrosive |
Risk Phrases | R34 |
Safety Phrases | S26-S36/37/39-S45 |
RIDADR | UN 2920 8/PG 2 |
WGK Germany | 3 |
Packaging Group | III |
Hazard Class | 3 |
HS Code | 29036990 |
Precursor 8 | |
---|---|
DownStream 9 | |
HS Code | 2903999090 |
---|---|
Summary | 2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors.
Eur. J. Med. Chem. 94 , 175-94, (2015) An approach for optimization of epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors using truncated thienopyrimidine structures combined with enzymatic assay has been evaluated. This... |
|
Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.
J. Comb. Chem. 11(1) , 34-43, (2009) For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib... |
|
Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.
J. Comb. Chem. 11 , 14-33, (2009) Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa... |
Toluene, α-chloro-3-fluoro- |
MFCD00000904 |
1-(Chloromethyl)-3-fluorobenzene |
Benzene, 1-(chloromethyl)-3-fluoro- |
Toluene, α-chloro-m-fluoro- |
α-Chloro-3-fluorotoluene |
G1R CF |
EINECS 207-264-8 |
m-Fluorobenzyl chloride |
α-Chloro-m-fluorotoluene |